Insider trading

Period: 120 months Stock: RARE + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

211 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

211 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

211 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

211 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
211 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
211 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

211 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Jun 2024
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold on a plan
$441.27K 9,806 at 45.00
14.5%
Planned (10b5-1)
10 Jun 2024
Sold on a plan
$71.39K 1,737 at 41.10
19.3%
Planned (10b5-1)
2 May 2024
Crombez Eric EVP and Chief Medical Officer
Sold at will
$15.46K 354 at 43.66
0.7%
Not planned
18 Apr 2024
Crombez Eric EVP and Chief Medical Officer
Sold at will
$6.26K 142 at 44.10
0.3%
Not planned
11 Mar 2024
Sold at will
$574.64K 11,509 at 49.93
4.4%
Not planned
7 Mar 2024
Fust Matthew K Director
Sold on a plan 3×
$620.44K 12,195 at 50.88
45.1%
Planned (10b5-1)
1 Mar 2024
Harris Erik EVP & Chief Commercial Officer
Sold at will
$256.33K 4,768 at 53.76
6.6%
Not planned
1 Mar 2024
Pinion John Richard See Remarks
Sold at will
$224.34K 4,173 at 53.76
4.5%
Not planned
1 Mar 2024
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold at will
$201.92K 3,756 at 53.76
5.3%
Not planned
1 Mar 2024
Crombez Eric EVP and Chief Medical Officer
Sold at will
$66.55K 1,238 at 53.76
2.5%
Not planned
1 Mar 2024
Sold at will
$54.35K 1,011 at 53.76
0.4%
Not planned
1 Mar 2024
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will
$18.33K 341 at 53.76
0.8%
Not planned
7 Feb 2024
KAKKIS EMIL D President & CEO
Sold at will
$1.35M 30,000 at 45.00
5.3%
Not planned
29 Dec 2023
KAKKIS EMIL D President & CEO
Sold at will
$1.44M 30,000 at 47.87
5.0%
Not planned
23 Oct 2023
Sold on a plan
$1.31M 39,878 at 32.78
13.9%
Planned (10b5-1)
19 Oct 2023
KAKKIS EMIL D President & CEO
Sold at will
$1.60M 47,853 at 33.52
7.4%
Not planned
7 Sep 2023
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will 2×
$88.25K 2,163 at 40.80
8.4%
Not planned
5 Sep 2023
Harris Erik EVP & Chief Commercial Officer
Sold at will
$227.76K 6,000 at 37.96
10.5%
Not planned
1 Sep 2023
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold at will 2×
$36.03K 970 at 37.15
3.9%
Not planned
30 Jun 2023
Sold at will
$27.35K 585 at 46.76
6.1%
Not planned
19 Jun 2023
Harris Erik EVP & Chief Commercial Officer
Sold at will
$14.70K 305 at 48.20
0.5%
Not planned
8 Jun 2023
Sold at will
$76.70K 1,485 at 51.65
13.4%
Not planned
18 May 2023
Pinion John Richard See Remarks
Sold at will
$100.60K 2,012 at 50.00
2.6%
Not planned
4 May 2023
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold at will
$197.01K 4,378 at 45.00
7.8%
Not planned
1 Mar 2023
Bedrosian Camille L EVP and Chief Medical Officer
Sold, plan not stated
$175.62K 3,881 at 45.25
7.7%
1 Mar 2023
Pinion John Richard See Remarks
Sold, plan not stated
$169.95K 3,755 at 45.26
4.5%
1 Mar 2023
Harris Erik EVP & Chief Commercial Officer
Sold, plan not stated
$165.80K 3,664 at 45.25
6.0%
1 Mar 2023
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold, plan not stated
$143.04K 3,161 at 45.25
5.3%
1 Mar 2023
Sold, plan not stated
$89.09K 1,968 at 45.27
0.8%
1 Mar 2023
Huang Dennis Karl See Remarks
Sold, plan not stated
$17.76K 389 at 45.65
0.5%
1 Mar 2023
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold, plan not stated
$4.57K 100 at 45.65
0.4%
28 Feb 2023
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold, plan not stated
$27.73K 639 at 43.40
3.9%
30 Dec 2022
KAKKIS EMIL D President & CEO
Sold, plan not stated
$892.35K 19,582 at 45.57
3.5%
21 Dec 2022
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold, plan not stated
$89.28K 2,031 at 43.96
11.1%
14 Oct 2022
Dier Mardi CFO & Executive Vice President
Sold, plan not stated
$65.42K 1,629 at 40.16
2.4%
12 Oct 2022
Dier Mardi CFO & Executive Vice President
Sold, plan not stated
$133.16K 3,484 at 38.22
4.9%
19 Jun 2022
Harris Erik EVP & Chief Commercial Officer
Sold, plan not stated
$16.16K 295 at 54.78
0.8%
16 Apr 2022
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold, plan not stated
$11.16K 132 at 84.55
0.8%
11 Mar 2022
Sold, plan not stated
$688.93K 10,281 at 67.01
4.3%
7 Mar 2022
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold, plan not stated
$323.56K 5,140 at 62.95
13.0%
3 Mar 2022
Dier Mardi CFO & Executive Vice President
Sold, plan not stated
$27.11K 420 at 64.55
0.8%
1 Mar 2022
Pinion John Richard See Remarks
Sold, plan not stated
$299.66K 4,498 at 66.62
9.0%
1 Mar 2022
Huang Dennis Karl See Remarks
Sold, plan not stated
$215.45K 3,234 at 66.62
8.1%
1 Mar 2022
Parschauer Karah Herdman EVP and Chief Legal Officer
Sold, plan not stated
$192.27K 2,886 at 66.62
10.2%
1 Mar 2022
Bedrosian Camille L EVP and Chief Medical Officer
Sold, plan not stated
$187.94K 2,821 at 66.62
7.7%
1 Mar 2022
Harris Erik EVP & Chief Commercial Officer
Sold, plan not stated
$180.74K 2,713 at 66.62
10.8%
1 Mar 2022
Sold, plan not stated
$158.16K 2,374 at 66.62
1.1%
1 Mar 2022
Huizenga Theodore Alan SVP, Chief Accounting Officer
Sold, plan not stated
$56.16K 843 at 66.62
6.0%
1 Mar 2022
Dier Mardi CFO & Executive Vice President
Sold, plan not stated
$35.58K 534 at 66.62
1.4%
30 Jan 2022
Bedrosian Camille L EVP and Chief Medical Officer
Sold, plan not stated
$109.86K 1,657 at 66.30
4.3%
Showing 51–100 of 211. ← Newer Page 2 of 5 Older →